Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

403

Full text

337

Free full text

124

Publication Types

Journal Article

409

Research Support, Non-U.S. Gov't

181

Clinical Trial

157

Randomized Controlled Trial

Multicenter Study

Clinical Trial, Phase II

Review

Comparative Study

Clinical Trial, Phase III

Research Support, U.S. Gov't, P.H.S.

Clinical Trial, Phase I

Research Support, N.I.H., Extramural

Case Reports

Observational Study

Controlled Clinical Trial

Meta-Analysis

Systematic Review

Research Support, U.S. Gov't, Non-P.H.S.

Equivalence Trial

Evaluation Study

Research Support, N.I.H., Intramural

Comment

Letter

Network Meta-Analysis

News

Publication Year

From

Quick links

Individual year

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Etoposide""[mesh_terms]

413 Results

Searching titles within these results

Islet Co-Expression of CD133 and ABCB5 in Human Retinoblastoma Specimens.

Marco Zschoche, Sergej Skosyrski, Neele Babst, Mahdy Ranjbar, Felix Rommel, Maximilian Kurz, Aysegül Tura, Stephanie C Joachim, Norbert Kociok, Vinodh Kakkassery

Klinische Monatsblatter fur Augenheilkunde 2023;240(7):878-886

Full Text

Abstract

Impact of Undernutrition on the Pharmacokinetics and Pharmacodynamics of Anticancer Drugs: A Literature Review.

Alejandro Pérez-Pitarch, Beatriz Guglieri-López, Amparo Nacher, Virginia Merino, Matilde Merino-Sanjuán

Nutrition and cancer 2017;69(4):555-563

Full Text

Abstract

Randomized phase-III study of low-dose cytarabine and etoposide + /- all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemia.

A Ganser, M Heuser, A Benner, R F Schlenk, D Weber, J Krzykalla, T Kindler, G Wulf, B Hertenstein, H R Salih, T Südhoff, J Krauter, U Martens, S Wessendorf, V Runde, H J Tischler, M Bentz, E Koller, F Thol, K Döhner, H Döhner

Scientific reports 2023;13(1):14809

Free Full Text

Abstract

Trifunctional Graphene Quantum Dot@LDH Integrated Nanoprobes for Visualization Therapy of Gastric Cancer.

Bin Wu, Kun Li, Feiyue Sun, Jintong Niu, Rongrong Zhu, Yechang Qian, Shilong Wang

Advanced healthcare materials 2021;10(16):e2100512

Free Full Text

Abstract

Secondary leukemia associated with the anti-cancer agent, etoposide, a topoisomerase II inhibitor.

Sachiko Ezoe

International journal of environmental research and public health 2012;9(7):2444-53

Free Full Text

Abstract

Cytotoxic treatment of adrenocortical carcinoma.

H Ahlman, A Khorram-Manesh, S Jansson, B Wängberg, O Nilsson, C E Jacobsson, S Lindstedt

World journal of surgery 2001;25(7):927-33

Full Text

Abstract

Topoisomerase II inhibitors.

Danko Martincic, Kenneth R Hande

Cancer chemotherapy and biological response modifiers 2005;22():101-21

Full Text

Recent advancements in the targeted delivery of etoposide nanomedicine for cancer therapy: A comprehensive review.

Razieh Behzadmehr, Sonia Fathi-Karkan, Rabia Arshad, Abbas Rahdar, Aghdas Ramezani, Suresh Ghotekar, Sadanand Pandey

European journal of medicinal chemistry 2023;259():115676

Full Text

Abstract

Imidazo-Pyrazole-Loaded Palmitic Acid and Polystyrene-Based Nanoparticles: Synthesis, Characterization and Antiproliferative Activity on Chemo-Resistant Human Neuroblastoma Cells.

Giulia Elda Valenti, Barbara Marengo, Marco Milanese, Guendalina Zuccari, Chiara Brullo, Cinzia Domenicotti, Silvana Alfei

International journal of molecular sciences 2023;24(19):15027

Free Full Text

Abstract

Mixed Primary Hepatocellular Carcinoma and Hepatic Neuroendocrine Carcinoma: Case Report and Literature Review.

Woo Young Shin, Keon Young Lee, Kyeong Deok Kim

Medicina (Kaunas, Lithuania) 2023;59(2):418

Free Full Text

Abstract

Group I pharmaceuticals of IARC and associated cancer risks: systematic review and meta-analysis.

Kwang-Pil Ko, Jung Eun Lee, Inah Kim, Sue K Park, Na Rae Lee, Sungji Moon, Woojin Lim, Ho Gyun Shin, Su-Yeon Yu

Scientific reports 2024;14(1):413

Free Full Text

Abstract

Phase II trial of intracerebrospinal fluid etoposide in the treatment of neoplastic meningitis.

Marc C Chamberlain, Denice D Tsao-Wei, Susan Groshen

Cancer 2006;106(9):2021-7

Free Full Text

Abstract

Antitumor properties of podophyllotoxin and related compounds.

M Gordaliza, M A Castro, J M del Corral, A S Feliciano

Current pharmaceutical design 2001;6(18):1811-39

Full Text

Abstract

Etoposide added to weekly leucovorin (LV)/5-fluorouracil (5-FU) in LV/5-FU pre-treated patients with advanced colorectal cancer.

Nicolas Tsavaris, Christos Kosmas, Kostas Gennatas, Maria Vadiaka, Platon Paliaros, Antonis Dimitrakopoulos, Theodoros Diamantis, Heraklis Tsipras, George Papastratis

Medical science monitor : international medical journal of experimental and clinical research 2003;8(9):PI65-9

Full Text

Abstract

The improved killing of both androgen-dependent and independent prostate cancer cells by etoposide loaded SPIONs coupled with NIR irradiation.

K Onbasli, M Erkısa, G Demirci, A Muti, E Ulukaya, A Sennaroglu, H Yagci Acar

Biomaterials science 2022;10(14):3951-3962

Full Text

Abstract

Results: 1 – 15 / 413

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Etoposide""[mesh_terms]

Islet Co-Expression of CD133 and ABCB5 in Human Retinoblastoma Specimens.

Impact of Undernutrition on the Pharmacokinetics and Pharmacodynamics of Anticancer Drugs: A Literature Review.

Randomized phase-III study of low-dose cytarabine and etoposide + /- all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemia.

Trifunctional Graphene Quantum Dot@LDH Integrated Nanoprobes for Visualization Therapy of Gastric Cancer.

Secondary leukemia associated with the anti-cancer agent, etoposide, a topoisomerase II inhibitor.

Cytotoxic treatment of adrenocortical carcinoma.

Topoisomerase II inhibitors.

Recent advancements in the targeted delivery of etoposide nanomedicine for cancer therapy: A comprehensive review.

Imidazo-Pyrazole-Loaded Palmitic Acid and Polystyrene-Based Nanoparticles: Synthesis, Characterization and Antiproliferative Activity on Chemo-Resistant Human Neuroblastoma Cells.

Mixed Primary Hepatocellular Carcinoma and Hepatic Neuroendocrine Carcinoma: Case Report and Literature Review.

Group I pharmaceuticals of IARC and associated cancer risks: systematic review and meta-analysis.

Phase II trial of intracerebrospinal fluid etoposide in the treatment of neoplastic meningitis.

Antitumor properties of podophyllotoxin and related compounds.

Etoposide added to weekly leucovorin (LV)/5-fluorouracil (5-FU) in LV/5-FU pre-treated patients with advanced colorectal cancer.

The improved killing of both androgen-dependent and independent prostate cancer cells by etoposide loaded SPIONs coupled with NIR irradiation.

Results for
""Etoposide""[mesh_terms]